Products for Research Use Only
RegisterLogin

XOMA-213

CAT: 0804-HY-P991358Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991358Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
XOMA-213 (LFA-102; X213) is a human monoclonal antibody (mAb) targeting PRLR/Prolactin Receptor. XOMA-213 inhibits hPRL-dependent growth of BaF3/hPRLR cells (EC50: 0.5 μg/mL) . XOMA-213 inhibits PRLR signaling and tumor growth in the Nb2-11-luc xenograft mouse model and the DMBA-induced rat breast cancer model. XOMA-213 can be used in Breast cancer, Hyperprolactinaemia and Prostate cancer research[1].
Product Name Alternative
LFA-102; X213
UNSPSC
12352203
Target
Estrogen Receptor/ERR
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[XOMA-213]
References & Citations
[1]Damiano JS, et al. Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer. Mol Cancer Ther. 2013 Mar;12 (3) :295-305.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991291XOMA 129
HY-P3459Tet-213
HY-177743TR-213
HY-107712-01TCN 213
HY-14327-01FAUC 213
HY-W999584CRBN ligand-213
HY-158373Anticancer agent 213
HY-163528Antibacterial agent 213
HY-P3459A-01Tet-213 (TFA)
HY-179096E3 Ligase Ligand-linker Conjugate 213

Alternative Products

CatalogName
T9901A-1565-01XOMA-213
PTX26204Anti-Human PRLR (XOMA 213)
MBS1581152-01Research Grade Anti-Human PRLR (XOMA 213)
A136614Anti-PRLR (XOMA 213) Biosimilar (Monoclonal, IgG)
T9901A-1102-01XOMA 129
M24286-01FAUC-213
pro-2075NCS1 213 a.a.
B5628-100ML 213
B5536-10TCN 213
C4770-50AG-213

Popular Products